G. Perez Mendoza (Las Palmas, Spain), I. Solovic (Vysne Hagy, Slovakia)
Public health guidance on programmatic management of latent tuberculosis infection in the European Union/European Economic Area
S. Rosales-Klintz (Solna, Sweden), M. Van Der Werf (Solna, Sweden)
|    |
TB status in a dynamic cohort of patients with Inflammatory Bowel Disease receiving immunosuppression treatment, with up to 8 years of follow-up.
M. Arias Guillen (Oviedo, Spain), R. De Francisco (Oviedo, Spain), S. Riestra-Menéndez (Oviedo, Spain), G. Muñiz-Albaiceta (Oviedo, Spain), M. González-Budiño (Oviedo, Spain), M. García-Clemente (Oviedo, Spain), C. Del Busto (Oviedo, Spain), M. Santibáñez-Margüello (Santander, Spain), A. Castaño-García (Oviedo, Spain), S. Martínez-González (Oviedo, Spain), C. Huidobro (Oviedo, Spain), L. Pérez-González (Oviedo, Spain), I. Ruiz-Alvarez (Oviedo, Spain), J. Herrero-Huertas (Oviedo, Spain), P. Ugarriza (Oviedo, Spain), V. Jiménez-Beltrán (Oviedo, Spain), P. Flórez-Díez (Oviedo, Spain), N. Rodríguez (Oviedo, Spain), C. Bailón (Oviedo, Spain), S. Gómez-Mañas (Oviedo, Spain), A. Losada-Dieguez (Oviedo, Spain), P. Escalante (Ro,MN, United States of America)
| |
Long-term incidence of tuberculosis among migrants according to migrant status: a cohort study
. Kristensen (Copenhagen, Denmark), T. Lillebaek (Copenhagen, Denmark), J. Petersen (Copenhagen, Denmark), S. Hargreaves (London, United Kingdom), L. Nellums (London, United Kingdom), J. Friedland (London, United Kingdom), P. Andersen (Copenhagen, Denmark), P. Ravn (Copenhagen, Denmark), M. Noerredam (Copenhagen, Denmark)
| |
Posttransplant tuberculosis in Europe – a TBnet study
B. Lange (Freiburg, Germany), S. Arend (Leiden, Netherlands), C. Armbruster (Freiburg, Germany), M. Arias-Guillén (Oviedo, Spain), M. Bakker (Rotterdam, Netherlands), C. Berastegui (Barcelona, Spain), M. Babiker (Coventry, United Kingdom), R. Charif (London, United Kingdom), R. Duarte (Porto, Portugal), H. Flick (Graz, Austria), R. Hofland (Utrecht, Netherlands), J. Ismail (London, United Kingdom), N. Krishnan (Coventry, United Kingdom), D. Kniepeiss (Graz, Austria), H. Kunst (London, United Kingdom), D. Kuijpers (Leiden, Netherlands), C. Lange (Borstel, Germany), V. Lezaic (Belgrade, Republic of Serbia), I. Los Arcos (Barcelona, Spain), J. Machova (Pilsen, Czech Republic), H. Milburn (London, United Kingdom), O. Kon (London, United Kingdom), C. Osoro Suarez (Oviedo, Spain), D. Pesut (Belgrade, Republic of Serbia), A. Rahman (London, United Kingdom), T. Reischig (Pilsen, Czech Republic), A. Sanchez Montalva (Barcelona, Spain), H. Spohn (Saarbrücken, Germany), M. Stegenga (Rotterdam, Netherlands), A. De Vries (Leiden, Netherlands), D. Wagner (Freiburg, Germany), R. Wobser (Freiburg, Germany), M. Sester (Saarbrücken, Germany)
| |
Treatment of severe Mycobacterium avium complex pulmonary disease with a adjunctive amikacin and clofazimine versus standard regimen alone, a retrospective study
S. Zweijpfenning (Nijmegen, Netherlands), S. Kops (Nijmegen, Netherlands), M. Boeree (Nijmegen, Netherlands), S. Kuipers (Nijmegen, Netherlands), J. Van Ingen (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands), C. Magis-Escurra (Nijmegen, Netherlands)
|  |
Do higher quantitative interferon gamma release assay or tuberculin skin test results help to predict incident tuberculosis? Data from the UK PREDICT study
R. Gupta (London, United Kingdom), M. Lipman (London, United Kingdom), C. Jackson (London, United Kingdom), A. Sitch (Birmingham, United Kingdom), J. Southern (London, United Kingdom), F. Drobniewski (London, United Kingdom), J. Deeks (Birmingham, United Kingdom), C. Tsou (London, United Kingdom), C. Griffiths (London, United Kingdom), J. Davidson (London, United Kingdom), C. Campbell (London, United Kingdom), O. Stirrup (London, United Kingdom), M. Noursadeghi (London, United Kingdom), H. Kunst (London, United Kingdom), P. Haldar (Leicester, United Kingdom), A. Lalvani (London, United Kingdom), I. Abubakar (London, United Kingdom)
| |
Impact of the introduction of a paediatric ‘virtual TB clinic’
L. Turnbull (Manchester, United Kingdom), F. Child (Manchester, United Kingdom)
| |
Whether Rv2346c enhances mycobacterial survival within macrophages and its mechanism
C. Sixia (Nangjing, China), F. Ganzhu (Nangjing, China)
| |